{"id":1718,"date":"2022-07-24T10:51:25","date_gmt":"2022-07-24T10:51:25","guid":{"rendered":"https:\/\/velico.ideademo.ie\/eu\/?p=1718"},"modified":"2024-06-07T20:10:59","modified_gmt":"2024-06-07T20:10:59","slug":"velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions","status":"publish","type":"post","link":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/","title":{"rendered":"Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions"},"content":{"rendered":"
\n
\n
\n

Spray dried plasma is being developed as an alternative to frozen plasma and is expected to play a life-saving role by making point-of-care plasma transfusion more accessible at the scene of significant bleeding and trauma, including pre-hospital emergency response, rural hospitals, military applications and mass casualty events.<\/em><\/p>\n

Beverly, Massachusetts \u2013 <\/strong>Velico\u00ae\u00a0Medical, an organization that is pioneering lifesaving innovation in transfusion medicine, today announced that the US Food and Drug Administration (FDA) has granted approval for the company to proceed with a Phase-I (human) clinical study for its proprietary FrontlineODP™ (On Demand Plasma) system for spray drying plasma. As a result of FDA\u2019s green light, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, executed a new contract (#75A50121C00059) with the company that will provide $20 million, with potential follow-on options up to a total of $74.3 million, in non-dilutive funding to support the continued research and development, scale up manufacturing and preparation for commercial launch.<\/p>\n

\u201cThis is a major step forward for Velico\u00ae Medical. Our entire team and a broad range of external advisors have worked tremendously hard for a number of years to get us to this point. I thank the people at BARDA for their continued support. We are looking forward to a successful clinical study while at the same time expanding the company\u2019s production and commercial capabilities,\u201d said Velico\u00ae Medical\u2019s CEO Richard Meehan.<\/p>\n

The work associated with the clinical study, further product development, manufacturing scale-up, building commercial readiness and PMA submission is being funded by the new contract. \u201cBARDA support has allowed us to advance this product to the exciting point where it is today. We are grateful for the significant funding commitment and the collaborative nature of our relationship with BARDA,\u201d said Bill Merritt Velico’s\u00ae Chief Program Officer.<\/p>\n

FrontlineODP™ is expected to be an easy to produce, easy to use, point-of-care plasma product for transfusion in settings where current plasma products (most often frozen) are unavailable or inconvenient to use because of challenging cold chain logistics and short dating. Velico\u00ae Medical\u2019s proprietary spray drying process results in a powdered plasma product that can be stored in a refrigerator or at ambient temperature and then reconstituted on-scene in minutes. With FrontlineODP™, plasma could become more readily available to first responders such as ground or air ambulances, in rural hospitals where plasma is typically not stocked, for the military and during mass casualty events.<\/p>\n

\u201cSpray-dried plasma would truly be a game-changer for Boston MedFlight, and likely for all Helicopter and Ground EMS providers.\u00a0The product\u2019s long shelf-stability and minimal form factor are critical for allowing us to bring the treatment to the point of injury and begin reversing coagulopathy as soon as possible.\u00a0Hemorrhagic resuscitation should start with plasma transfusion, but the challenge of safe and effective storage in the back of a helicopter, often precludes our ability to utilize it.\u00a0Additionally, plasma\u2019s short shelf-life results in the potential waste of precious blood products and un-recouped expenses.\u00a0We are a non-profit organization and the loss of every unit of blood product takes away directly from our life-saving mission,\u201d said Dr. Jason Cohen DO, FACEP, FCCM, Chief Medical Officer at Boston MedFlight.<\/p>\n

Using Velico\u00ae Medical\u2019s spray drying technology and associated products, FrontlineODP™ will be produced by blood centers around the world. These centers have the infrastructure and expertise to provide a sustainable source of dried plasma to service local and regional needs while also supporting national disaster preparedness initiatives.<\/p>\n

\u201cOur clinical partners and study sites, renowned in their own right, are very excited about working with us to contribute to the advancement of FrontlineODP™, while also helping us develop regulatory compliant protocols and processes. Working together we hope to aid in saving thousands of lives all over the world,\u201d said Velico\u00ae Medical\u2019s Chief Medical Officer Mark Popovsky M.D.<\/p>\n

About Velico\u00ae Medical<\/strong><\/p>\n

Velico\u00ae Medical, Inc. is a private US medical technology company, committed to the mission of eliminating preventable death from bleeding. Headquartered in Beverly, Massachusetts, USA, Velico has been in business since 1992 (originally ZymeQuest). Velico personnel have substantial expertise and experience in transfusion medicine and medical device development. Velico\u00ae intends to equip regional blood centers around the world to respond to the urgent clinical need for a locally produced, consistently available, point of care, dry plasma product for transfusion. In support of its mission, Velico\u00ae is developing partnerships with civilian, government and military blood center leadership, trauma surgeons, emergency medical physicians, military medics and first responders worldwide.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Spray dried plasma is being developed as an alternative to frozen plasma and is expected to play a life-saving role by making point-of-care plasma transfusion more accessible at the scene of significant bleeding and trauma, including pre-hospital emergency response, rural hospitals, military applications and mass casualty events. Beverly, Massachusetts \u2013 Velico\u00ae\u00a0Medical, an organization that is… Continue reading Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-1718","post","type-post","status-publish","format-standard","hentry","category-velico-news","entry"],"acf":[],"yoast_head":"\nVelico Medical Acquires Entegrion Inc\u2019s Resusix Product Portfolio<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Velico Medical Acquires Entegrion Inc\u2019s Resusix Product Portfolio\" \/>\n<meta property=\"og:description\" content=\"Spray dried plasma is being developed as an alternative to frozen plasma and is expected to play a life-saving role by making point-of-care plasma transfusion more accessible at the scene of significant bleeding and trauma, including pre-hospital emergency response, rural hospitals, military applications and mass casualty events. Beverly, Massachusetts \u2013 Velico\u00ae\u00a0Medical, an organization that is… Continue reading Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions\" \/>\n<meta property=\"og:url\" content=\"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/\" \/>\n<meta property=\"og:site_name\" content=\"Velico EU\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-24T10:51:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-07T20:10:59+00:00\" \/>\n<meta name=\"author\" content=\"idea-developer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"idea-developer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/\"},\"author\":{\"name\":\"idea-developer\",\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/#\\\/schema\\\/person\\\/3d773200ac63850683dd1de2fcb54748\"},\"headline\":\"Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions\",\"datePublished\":\"2022-07-24T10:51:25+00:00\",\"dateModified\":\"2024-06-07T20:10:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/\"},\"wordCount\":788,\"articleSection\":[\"Velico\u00ae News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/\",\"url\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/\",\"name\":\"Velico Medical Acquires Entegrion Inc\u2019s Resusix Product Portfolio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/#website\"},\"datePublished\":\"2022-07-24T10:51:25+00:00\",\"dateModified\":\"2024-06-07T20:10:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/#\\\/schema\\\/person\\\/3d773200ac63850683dd1de2fcb54748\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/#website\",\"url\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/\",\"name\":\"Velico EU\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/#\\\/schema\\\/person\\\/3d773200ac63850683dd1de2fcb54748\",\"name\":\"idea-developer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/79a8fd2555da30c88460c11968444e34b85ebee75c6a5963c96a091c55109f3d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/79a8fd2555da30c88460c11968444e34b85ebee75c6a5963c96a091c55109f3d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/79a8fd2555da30c88460c11968444e34b85ebee75c6a5963c96a091c55109f3d?s=96&d=mm&r=g\",\"caption\":\"idea-developer\"},\"sameAs\":[\"http:\\\/\\\/velico.ideademo.ie\"],\"url\":\"https:\\\/\\\/velico.ideademo.ie\\\/eu\\\/author\\\/idea-developer\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Velico Medical Acquires Entegrion Inc\u2019s Resusix Product Portfolio","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Velico Medical Acquires Entegrion Inc\u2019s Resusix Product Portfolio","og_description":"Spray dried plasma is being developed as an alternative to frozen plasma and is expected to play a life-saving role by making point-of-care plasma transfusion more accessible at the scene of significant bleeding and trauma, including pre-hospital emergency response, rural hospitals, military applications and mass casualty events. Beverly, Massachusetts \u2013 Velico\u00ae\u00a0Medical, an organization that is… Continue reading Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions","og_url":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/","og_site_name":"Velico EU","article_published_time":"2022-07-24T10:51:25+00:00","article_modified_time":"2024-06-07T20:10:59+00:00","author":"idea-developer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"idea-developer","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/#article","isPartOf":{"@id":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/"},"author":{"name":"idea-developer","@id":"https:\/\/velico.ideademo.ie\/eu\/#\/schema\/person\/3d773200ac63850683dd1de2fcb54748"},"headline":"Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions","datePublished":"2022-07-24T10:51:25+00:00","dateModified":"2024-06-07T20:10:59+00:00","mainEntityOfPage":{"@id":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/"},"wordCount":788,"articleSection":["Velico\u00ae News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/","url":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/","name":"Velico Medical Acquires Entegrion Inc\u2019s Resusix Product Portfolio","isPartOf":{"@id":"https:\/\/velico.ideademo.ie\/eu\/#website"},"datePublished":"2022-07-24T10:51:25+00:00","dateModified":"2024-06-07T20:10:59+00:00","author":{"@id":"https:\/\/velico.ideademo.ie\/eu\/#\/schema\/person\/3d773200ac63850683dd1de2fcb54748"},"breadcrumb":{"@id":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/velico.ideademo.ie\/eu\/velico-medical-achieves-two-significant-milestones-in-developing-spray-dried-plasma-for-lifesaving-point-of-care-transfusions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/velico.ideademo.ie\/eu\/"},{"@type":"ListItem","position":2,"name":"Velico\u00ae Medical achieves two significant milestones in developing spray dried plasma for lifesaving point-of-care transfusions"}]},{"@type":"WebSite","@id":"https:\/\/velico.ideademo.ie\/eu\/#website","url":"https:\/\/velico.ideademo.ie\/eu\/","name":"Velico EU","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/velico.ideademo.ie\/eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/velico.ideademo.ie\/eu\/#\/schema\/person\/3d773200ac63850683dd1de2fcb54748","name":"idea-developer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/79a8fd2555da30c88460c11968444e34b85ebee75c6a5963c96a091c55109f3d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/79a8fd2555da30c88460c11968444e34b85ebee75c6a5963c96a091c55109f3d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/79a8fd2555da30c88460c11968444e34b85ebee75c6a5963c96a091c55109f3d?s=96&d=mm&r=g","caption":"idea-developer"},"sameAs":["http:\/\/velico.ideademo.ie"],"url":"https:\/\/velico.ideademo.ie\/eu\/author\/idea-developer\/"}]}},"_links":{"self":[{"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/posts\/1718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/comments?post=1718"}],"version-history":[{"count":4,"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/posts\/1718\/revisions"}],"predecessor-version":[{"id":2150,"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/posts\/1718\/revisions\/2150"}],"wp:attachment":[{"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/media?parent=1718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/categories?post=1718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/velico.ideademo.ie\/eu\/wp-json\/wp\/v2\/tags?post=1718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}